A Comparison of Changes in the Fatty Acid Profile of Human Milk of Spanish Lactating Women during the First Month of Lactation Using Gas Chromatography-Mass Spectrometry. A Comparison with Infant Formulas by Sánchez Hernández, Silvia et al.
nutrients
Article
A Comparison of Changes in the Fatty Acid Profile of
Human Milk of Spanish Lactating Women during the
First Month of Lactation Using Gas
Chromatography-Mass Spectrometry. A Comparison
with Infant Formulas
Silvia Sánchez-Hernández 1,2,*, Adelaida Esteban-Muñoz 1,2, Rafael Giménez-Martínez 1,3,
María José Aguilar-Cordero 4, Beatriz Miralles-Buraglia 5 and Manuel Olalla-Herrera 1,3
1 Department of Nutrition and Bromatology, University of Granada, 18071 Granada, Spain;
aidaem@ugr.es (A.E.-M.); rafaelg@ugr.es (R.G.-M.); olalla@ugr.es (M.O.-H.)
2 Programme in Nutrition and Food Science, University of Granada, 18071 Granada, Spain
3 Instituto de Investigación Biosanitaria, 18071 Granada, Spain
4 Department de Nursing, University of Granada, 18071 Granada, Spain; mariajaguilar@telefonica.net
5 Institute of Food Science Research (CIAL), CSIC-UAM, 28049 Madrid, Spain; beatriz.miralles@csic.es
* Correspondence: silsanchez@ugr.es
Received: 13 November 2019; Accepted: 12 December 2019; Published: 14 December 2019 
Abstract: Breastfeeding is the ideal way to provide infants with the nutrients they need for healthy
growth and development. Milk composition changes throughout lactation, and fat is one of the
most variable nutrients in human milk. The aim of this study was to determine the main differences
between the fatty acid (FA) profile of human milk samples (colostrum, transitional, and mature
milk group) and infant formulas. Human milk samples were provided by lactating women from
Granada. Moreover, different commercial infant formulas were analyzed. FAs were determined using
gas chromatography coupled with mass spectrometry. According to the results, oleic acid was the
predominant monounsaturated fatty acid (41.93% in human milk and 43.53% in infant formulas),
while palmitic acid was the most representative saturated fatty acid (20.88% in human milk and
23.09% in infant formulas). Significant differences were found between human milk groups and infant
formulas, mainly in long-chain polyunsaturated FAs (LC-PUFAs). The content of araquidonic acid
(AA) and docoxahexaenoic acid (DHA) was higher in human milk (0.51% and 0.39%, respectively)
than in infant formulas (0.31% and 0.22%, respectively). Linoleic acid (LA) percentage (15.31%) in
infant formulas was similar to that found in human milk (14.6%). However, α-linolenic acid (ALA)
values were also much higher in infant formulas than in human milk (1.64% and 0.42%, respectively).
Keywords: fatty acids; human milk; infant formula; GC-MS/MS; LC-PUFA
1. Introduction
Breastfeeding is the ideal way to provide young children with the nutrients they need for healthy
growth and development [1]. The World Health Organization (WHO) and the United Nations International
Emergency Fund for Children (UNICEF) adopted measures in 2002 to promote global health. As a part of
this, the global strategy for optimal food use in infants and young children recommended breastfeeding
from the first hour of life, continuing with exclusive breastfeeding during the first 6 months of life and
further breastfeeding up to 2 years of age which is supplemented with other foods [2,3]. Data published
in 2016 by UNICEF indicates that, overall, only 43% (2 out of 5) of children continue to receive exclusive
breastfeeding at 6 months of age [4]. This is because some mothers cannot or choose not to breastfeed and
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instead use infant formulas (IF) as a substitute. IF are manufactured foodstuffs for feeding newborns and
babies that attempts to match, as much as possible, the composition of human milk (HM), especially the
lipid profile [5]. Lipids are the largest source of energy in human milk. Triacylglycerols (TAGs) represent
98–99% of total fats and their properties are determined by the length of and degree of unsaturation of
fatty acids (FAs) esterified to the glycerol backbone [6]. Milk composition changes throughout lactation,
and fat is one of the most variable nutrients in human milk. Lipid content changes according to the stage
of lactation and time of day, and during feeding. Whilst in human milk the composition of fatty acids is
dynamic and modulated by maternal diet, infant formulas have a much less complex composition than
human milk fat [6–8]. This can provide challenges in attempting to ensure normal or typical fatty acid
intake in breastfed infants and in establishing fatty acid targets when developing infant formulas [8].
Human milk contains the parent essential fatty acids (EFA) linoleic acid (LA, C18:2 n-6) and
α-linolenic acid (ALA, C18:3 n-3), and n-3/n-6 very long-chain polyunsaturated fatty acids (LC-PUFA) [9].
A balanced amount of these fatty acids is required for normal maturation and functioning of the
nervous system [10]. These fatty acids are also associated with the development of allergic diseases and
inflammatory responses [11]. They regulate growth, alongside visual, cognitive, and motor development
during the first year of life [12–15].
LC-PUFA are present in human milk in concentrations greater than in other commercially available
milks [16]. This is biologically relevant since the two major LC-PUFA are arachidonic acid (AA, C20:4
n-6) and docosahexaenoic acid (DHA, C22:6 n-3). These accumulate in the fetal retina and brain during
the last trimester of pregnancy and the early period of postnatal development when milk represents
the only source of fat [13,16].
Infant formulas provide all of these essential nutrients for adequate growth and development.
These nutrients include the LA and ALA, as required by regulatory agencies [17], although the addition
of LC-PUFA as AA and DHA is not mandated [18].
In recent years, variability of the fatty acid profile in human milk and in infant feeding has become
very important. For this, the aim of the present study was:
(1) To determine the main differences between the fatty acid profile of human milk samples at
three stages of lactation (colostrum, transitional, and mature milk group) in women from Granada and
compare the fatty acid profile of human milk with different commercially available infant formulas in
Spain. This will provide new fatty acid data through use of novel analytical techniques.
(2) To study the relationship between different milk samples according to their FA composition
and determine which fatty acids are mostly responsible for the differences found between human milk
samples and infant formulas.
2. Materials and Methods
2.1. Chemicals and Reagents
Fatty acid methyl esters (Supelco 35 Component FAME Mix) were obtained from Sigma-Aldrich SL
(Madrid, Spain). N-hexane, isopropanol, anhydrous sodium sulfate, undecanoic acid (C11:0), methyl
acetate, sodium methoxide, methanol, oxalic acid, and diethyl ether were acquired from Panreac
Química SL (Panreac AppliChem, Barcelona, Spain) and Sigma-Aldrich (Merck, Munich, Germany).
All reagents were of analytical grade.
2.2. Subject
The present research was carried out in the obstetrics department of one of the six regional
hospitals of Andalusia “Hospital Universitario Virgen de las Nieves”. Of all of the participants who
formed part of this study, the three samples of human milk (colostrum, transitional, and mature milk)
were donated by only thirteen lactating mothers due to the complexity of obtaining these samples.
Details of the study were explained to all mothers who voluntarily gave written consent to participate.
The characteristics of the study sample were as follows: women aged 18–40, who had given birth
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to healthy babies in the “Hospital Universitario Virgen de las Nieves”. This also constituted the
inclusion criteria.
Ethical approval for this study was provided by the “Hospital Virgen de las Nieves” Ethics and
Scientific Committee and the trial was registered at ClinicalTrials.gov.
The mean age of participating mothers was 32 ± 4.7 years, of which eight reported this being their
first lactation/child (N1, N2, N3, N5, N6, N10, N11, and N12).
The main characteristics of sampled mothers are shown in Table 1.
Table 1. Characteristics of the sampled mothers.
Mean SD Minimum Maximum
Age (years) 32 4.7 26 40
Height (cm) 163.6 7.00 150.0 172.0
Weight (kg) 69.6 13.50 47.4 90.8
BMI (kg/cm2) 26.2 5.33 18.4 33.4
Birth weight (kg) 2.9 0.79 1.2 3.8
Parity 1.6 0.92 1 3
BMI: body mass index; SD: standard deviation.
2.3. Milk Samples
Thirty-eight milk samples were categorized according to the length of time post-partum. Samples
obtained between the 1st and 5th day post-delivery were assigned to the colostrum group (n = 13,
1.75 ± 0.53 days) with the Marmet manual extraction technique being used for delivery [19]; samples
obtained between the 6th and 15th day post-delivery were assigned to the transitional group (n = 13,
12.83 ± 4.43 days); and samples obtained after the 15th day post-delivery were assigned to the mature
milk group (n = 12, 24.75 ± 9.77 days). For both of the latter groups, milk extraction was achieved by
means of a mechanical breast pump (Medela®, Medela, Switzerland) following the manufacturer’s
instructions. Milk from each breast was obtained at both the beginning and end of each feed.
All human milk samples collected from study participants were aliquoted and immediately stored
at −70 ◦C until extraction.
In addition to the human milk samples, seven different initiation formulas (0–6 months) for
full-term infants were also analyzed. These are the most commonly consumed infant formulas and
include brands such as Nestlé, Combiotik, Blemil, Nutribén, and Almirón, and were purchased in
different commercial and agricultural areas of the market. They were randomly coded as IF 1–7
(Table S1). All samples were analyzed in triplicate.
2.4. Total Lipid Content and Fat Extraction
Infant formulas were reconstituted in water following the manufacturer’s instructions.
The human milk samples and infant formulas were extracted with a mixture of solvents according
to the method of Hara and Radin [20].
First, 500 µL of milk was mixed with 1.8 mL of n-hexane, isopropanol (3:2, v/v), then and homogenized.
Next, 1.2 mL of aqueous sodium sulfate was added and centrifuged to separate the layers. The organic layer
was evaporated using nitrogen (N2). The aqueous phase was re-extracted, and the lipid recovered and
stored at −18 ◦C in n-hexane: isopropanol (4:1, v/v) until the fatty acid methyl esters (FAME) were prepared.
2.5. Preparation of Methyl Esters for Gas Chromatographic Analysis
Fatty acid methyl esters (FAME) were obtained after following the base-catalyzed transesterification
method described by Christie WW. [21]. The previously evaporated sample was dissolved in 0.5 mL
of n-hexane. 40 µL of methyl acetate and 80 µL of sodium methoxide in methanol (0.5 M) were added.
The solution was mixed for 30 s and left for 15 min at room temperature, at which time the reaction was
stopped by adding 30 µL of a saturated solution of oxalic acid in diethyl ether. After a brief agitation,
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the mixture was centrifuged at 1500× g for 2 min and the supernatant, containing FAME, was collected
into chromatography vials.
2.6. Chromatographic and Mass Operating Conditions
Determination of fatty acids was conducted using a mass spectrometer with tandem quadrupole
model QUATTRO micro GC (WATERS, Milford, MA, USA), equipped with a split/splitless injector.
A Flame Ionization Detector (FID) type detector with ionization mode EI+ at 300 ◦C was used, measuring
a mass range of 45 to 450 and a 35 min chromatogram, and a capillary column with a length of 30.0 m
and a diameter of 250 µm. The temperature of the initial oven was 100 ◦C with a maximum of 350 ◦C.
The injection volume was 1 µL and the split ratio was set at 10.0 and split flow 10.0 mL/min.
All data was collected using MassLynx V4.1 software (Waters Inc., 2010, Milford, MA, USA). Peaks
were identified by comparing retention times with standard mixtures. Fatty acids were quantified by
comparing the peak area of each compound with that of the standard.
2.7. Analytical Validation
Validation was carried out by studying the parameters of linearity, linear range, limit of detection
(LOD), and limit of quantification (LOQ), following the guidelines for the validation of analytical
methods (AOAC, 2012). Linearity in all fatty acids was achieved in their dynamic range of between
250–1000 ppm. A total of 35 fatty acids were identified and quantified in the different milk samples.
This is a highly sensitive and precise analytical method based on mass spectrometry combined
with high resolution separation methods.
2.8. Statistical Analyses
The homogeneity of variance was assessed using the Levene test and normality of data distribution
of the samples was examined with the Shapiro–Wilk test.
Results of individual FA content of the different human milk samples and infant formulas were
analyzed using one-way ANOVA followed by the Tukey test in order to compare significant variations
between means (p < 0.05). Moreover, in order to verify the capacity of the FA analysis as a tool for human
milk characterization, a multivariate discriminant analysis was performed. Graphical representation
of this analysis allows the similarity of samples to be assessed according to their FA composition.
The significance level was set at 5% (p < 0.05) in all tests. SPSS 15.0 for Windows (IBM SPSS Inc.,
Chicago, IL, USA) was used for data analyses.
In order to complete the examination of the fatty acid profile of human milk and infant formulas,
the results obtained were subjected to discriminant analysis. This analysis is aimed at supporting the
interpretation of complex multivariate data. It considers all observations as a single group with the
aim of uncovering the variables with the greatest influence, so that observations can be grouped and
predictive groups formed. The data obtained were expressed as means ± standard deviations (SD).
3. Results
3.1. Analytical Validation
A chromatogram of the standards of these fatty acids over a period of 35 min is shown in Figure 1.
Table 2 shows the linear range, retention time, adjusted linear equations, correlation coefficients,
detection limits, and quantification limits of the standards.
A favorable correlation between the experimental data and the theoretical values was obtained
with good linearity in the ranges evaluated and correlation coefficients (R2) greater than 0.998.
The highest LOD and LOQ corresponded to α-linolenic acid (C18:3 n-3) (1.8403 and 6.1344) and
the lowest to arachidonic acid (C20:4 n-6) (0.1345 and 0.4482). These LOD and LOQ were compared
with values previously reported by other authors for fatty acids using GC-MS/MS methods.
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Table 2. Quality parameters for the chromatographic determination of fatty acid standards.
Fatty Acids Linear Range (ppm) tr ± SD Linear Equation R R2 LOD (ppm) LOQ (ppm)
Caprylic acid (C8:0) 250–1000 2.647 ± 0.006 y = 271.7940x + 813.2345 0.9999 0.9997 0.3362 1.1208
Capric acid (C10:0) 250–1000 4.597 ± 0.006 y = 362.0136x - 8269.8440 0.9999 0.9997 0.3223 1.0743
Undecanoic acid (C11:0) 250–1000 6.000 ± 0.000 y = 183.0014x - 4785.7425 0.9999 0.9998 0.4375 1.4583
Lauric acid (C12:0) 250–1000 7.623 ± 0.006 y = 403.2163x - 11475.9145 0.9998 0.9996 0.2929 0.9765
Tridecanoic acid (C13:0) 250–1000 9.400 ± 0.010 y = 197.6763x - 6117.3745 0.9999 0.9999 0.5236 1.7452
Myristic acid (C14:0) 250–1000 11.247 ± 0.006 y = 414,5987x - 8987,9605 0.9994 0.9988 0.1620 0.5400
Myristoleic acid (C14:1) 250–1000 12.167 ± 0.006 y = 217,1785x - 9140,8480 0.9993 0.9987 0.1514 0.5046
Pentadecanoic acid (C15:0) 250–1000 13.117 ± 0.012 y = 211,0244x - 6724,5895 0.9996 0.9993 0.2058 0.6862
Cis-10-pentadecenoic acid (C15:1) 250–1000 14.010 ± 0.010 y =221,6763 x - 9651,3250 0.9999 0.9998 0.2058 0.6862
Palmitic acid (C16:0) 250–1000 14.980 ± 0.010 y = 663,2947x - 24193,3435 0.9999 0.9998 0.3793 1.2642
Palmitoleic acid (C16:1 n-9 Z) 250–1000 15.587 ± 0.006 y = 227,0054x - 8233,3830 0.9996 0.9991 0.1901 0.6337
Margaric acid (C17:0) 250–1000 16.793 ± 0.006 y = 147,9136x - 5182,7135 1.0000 1.0000 0.9664 3.2212
Cis-10-heptadecenoic acid (C17:1) 250–1000 17.357 ± 0.006 y = 229,9246x - 10188,1020 0.9999 0.9998 0.4456 1.4855
Stearic acid (C18:0) 250–1000 18.577 ± 0.006 y = 464,1352x - 13723,7815 0.9997 0.9995 0.2437 0.8123
Elaidic acid (C18:1 n-9 E) 250–1000 18.817 ± 0.006 y = 158.1385x - 2278.2970 1.0000 0.9999 0.6563 2.1877
Oleic acid (C18:1 n-9 Z) 250–1000 18.953 ± 0.006 y = 425.2101x - 7612.0155 0.9997 0.9993 0.2137 0.7122
Linolelaidic acid (C18:2 n-6 E) 250–1000 19.553 ± 0.006 y = 230.1367x - 15194.7850 0.9997 0.9994 0.2214 0.7380
Linoleic acid (C18:2 n-6 Z) 250–1000 19.920 ± 0.000 y = 223.0317x - 11160.5665 1.0000 0.9999 0.6918 2.3060
γ-linolenic acid (C18:3 n-6, GLA) 250–1000 20.580 ± 0.000 y = 212.2357x - 12443.1135 1.0000 0.9999 0.7184 2.3946
α-linolenic acid (C18:3 n-3, ALA) 250–1000 21.160 ± 0.000 y = 202.2944x - 9492.2895 1.0000 1.0000 1.8403 6.1344
Arachidic acid (C20:0) 250–1000 21.973 ± 0.015 y = 494.0689x - 16256.6330 0.9991 0.9983 0.1345 0.4482
Cis-11-eicosenoic acid (C20:1) 250–1000 22.263 ± 0.006 y = 241.1562x - 12764.6795 1.0000 1.0000 0.8160 2.7199
Cis-11,14-eicosadienoic acid (C20:2) 250–1000 23.130 ± 0.010 y = 211.9830x - 9814.0900 0.9998 0.9996 0.2733 0.9110
Heneicosanoic acid (C21:0) 250–1000 23.590 ± 0.010 y = 150.6156x - 2443.3555 1.0000 1.0000 1.6576 5.5254
Cis-8,11,14-eicosatrienoic acid (C20:3 n-6, DGLA) 250–1000 23.687 ± 0.006 y = 197.8801x - 7653.1285 0.9998 0.9996 0.2765 0.9218
Arachidonic acid (C20:4 n-6, AA) 250–1000 24.103 ± 0.006 y = 194.4791x - 7437.3125 0.9998 0.9995 0.2568 0.8560
Cis-11,14,17-eicosatrienoic acid (C20:3) 250–1000 24.253 ± 0.006 y = 141.3401x - 3637.9235 0.9992 0.9984 0.1398 0.4659
Behenic acid (C22:0) 250–1000 25.180 ± 0.010 y = 408.6182x - 10400.1250 1.0000 0.9999 0.7288 2.4292
Erucic acid (C22:1 n-9) 250–1000 25.313 ± 0.006 y = 221.7645x - 17072.2935 1.0000 0.9999 0.7788 2.5959
5,8,11,14,17-eicosapentadienoic acid (C20:5 n-3, EPA) 250–1000 25.407 ± 0.006 y = 199.8515x - 10168.5900 0.9997 0.9994 0.2339 0.7797
Cis-13,16-docosadienoic acid (C22:2) 250–1000 26.173 ± 0.006 y = 213.4314x - 12761.5080 1.0000 0.9999 0.6514 2.1713
Tricosanoic acid (C23:0) 250–1000 26.710 ± 0.010 y = 228.7863x - 7187.5190 0.9997 0.9994 0.2318 0.7728
Lignoceric acid (C24:0) 250–1000 28.213 ± 0.006 y = 443.1121x - 25091.8985 0.9999 0.9999 0.5220 1.7401
Nervonic acid (C24:1) 250–1000 28.373 ± 0.006 y = 228.3534x - 11611.2500 1.0000 1.0000 1.0994 3.6648
Cis-4,7,10,13,16,19-docosahexadienoic acid (C22:6 n-3, DHA) 250–1000 28.630 ± 0.000 y = 215.8342x - 19113.3950 1.0000 0.9999 0.5976 1.9921
tr: retention time; SD: standard deviation; R: correlation coefficient; R2: squared correlation coefficient; LOD: limit of detection; LOQ: limit of quantification.
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3.2. Fatty Acid Profile
The fatty acid composition of colostrum, transitional, and mature milk samples of women from
Granada, as well as that of infant formulas marketed are presented in Tables 3–5. Of the thirty-five
standard fatty acids, a total of twenty-eight fatty acids were identified and quantified in our human
milk and infant formula samples using GC-MS/MS analysis. These were grouped into saturated (SFAs),
monounsaturated (MUFAs), and polyunsaturated (PUFAs) fatty acids. Figure 2 shows the distribution
of the main fatty acid groups in the different samples of human milk and infant formulas.
Table 3. Saturated fatty acid (SFAs) composition of colostrum, transitional, and mature milks, and
infant formulas (% wt = wt).
Fatty Acids (FAs) Colostrum Transitional Milk Mature Milk Infant Formula
Caprylic acid (C8:0) 0.72 ± 0.634 0.51 ± 0.130 0.64 ± 0.197 0.77 ± 0.271
Capric acid (C10:0) 0.18 a,b,d ± 0.160 1.06 ± 0.268 1.06 ± 0.173 1.04 ± 0.424
Lauric acid (C12:0) 1.43 a,b,d ± 0.768 4.65 e ± 1.578 3.82 f ± 1.158 7.45 ± 2.378
Tridecanoic acid (C13:0) 0.00 0.01 ± 0.020 0.00 0.01 ± 0.010
Myristic acid (C14:0) 3.79 ± 1.165 4.56 ± 1.420 3.68 ± 1.326 3.43 ± 1.517
Pentadecanoic acid (C15:0) 0.15 ± 0.140 0.22 ± 0.009 0.18 ± 0.093 0.15 ± 0.282
Palmitic acid (C16:0) 23.75 a,b ± 2.032 20.76 c ± 2.031 18.13 f ± 2.332 23.09 ± 2.669
Margaric acid (C17:0) 0.09 ± 0.133 0.07 ± 0.104 0.08 ± 0.109 0.05 ± 0.109
Stearic acid (C18:0) 6.23 d ± 1.192 5.54 e ± 0.906 5.46 f ± 0.781 3.81 ± 0.516
Arachidic acid (C20:0) 0.04 d ± 0.096 0.02 e ± 0.074 0.03 f ± 0.075 0.33 ± 0.110
Lignoceric acid (C24:0) 0.04 ± 0.144 0.00 0.00 0.00
SFA 36.05 ± 5.266 37.49 ± 3.153 33.19 ± 4.899 37.31 ± 4.522
SC-SFA (C8-C10) 0.97 a,b,d ± 0.622 1.51 ± 0.346 1.70 ± 0.266 2.01 ± 0.465
MC-SFA (C12-C16) 27.71 d ± 3.305 30.38 c ± 2.856 26.05 f ± 4.370 33.76 ± 4.219
LC-SFA (> C17) 6.41 b,d ± 1.153 5.35 ± 0.901 5.55 f ± 0.735 4.15 ± 0.451
SD: standard deviation; SFA: saturated FAs; SC-SFA: short-chain SFA; MC-SFA: medium-chain SFA; LC-SFA:
long-chain SFA. (a) Significant differences (p < 0.05) between colostrum and transitional milk groups, (b) significant
differences (p < 0.05) between colostrum and mature milk groups, (c) significant differences (p < 0.05) between
transitional and mature milk groups, (d) significant differences (p < 0.05) between colostrum and infant formula
groups, (e) significant differences (p < 0.05) between transitional and infant formula groups, (f) significant differences
(p < 0.05) between mature and infant formula groups.
Table 4. Monounsaturated fatty acid (MUFAs) composition of colostrum, transitional, mature milk,
and infant formulas (% wt = wt).
Fatty Acids (FAs) Colostrum Transitional Milk Mature Milk Infant Formula
Myristoleic acid (C14:1) 0.02 a ± 0.064 0.08 ± 0.085 0.06 ± 0.0796 0.18 ± 0.328
Cis-10-pentadecenoic acid (C15:1) 0.00 0.00 0.00 0.01 ± 0.034
Palmitoleic acid (C16:1 n-9 Z) 1.52 d ± 0.320 1.23 e ± 0.667 1.45 f ± 0.416 0.37 ± 0.159
Vaccenic acid (C18:1 n-7 E) 1.42 a,b,d ± 0.148 1.12 e ± 0.161 1.11 f ± 0.099 0.47 ± 0.103
Oleic acid (C18:1 n-9 Z) 42.11 ± 5.228 39.81 ± 4.608 43.88 ± 7.041 43.54 ± 3.428
Gadoleic acid (C20:1 n-9) 0.97 a,b,d ± 0.253 0.52 e ± 0.173 0.38 ± 0.097 0.36 ± 0.046
Erucic acid (C22:1 n-9) 0.00 0.03 ± 0.066 0.01 ± 0.035 0.00
MUFA 45.99 ± 5.750 43.34 ± 4.754 46.99 ± 6.796 44.86 ± 3.689
SD: standard deviation; MUFA: monounsaturated fatty acids. (a) Significant differences (p < 0.05) between colostrum
and transitional milk groups, (b) significant differences (p < 0.05) between colostrum and mature milk groups, (c)
significant differences (p < 0.05) between transitional and mature milk groups, (d) significant differences (p < 0.05)
between colostrum and infant formula groups, (e) significant differences (p < 0.05) between transitional and infant
formula groups, (f) significant differences (p < 0.05) between mature and infant formula groups.
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Table 5. Polyunsaturated fatty acid (PUFAs) composition of colostrum, transitional, and mature milk,
and infant formulas (% wt = wt).
Fatty Acids (FAs) Colostrum Transitional Milk Mature Milk Infant Formula
Cis-9,12-hexadecadienoic (C16:2 n-4) 0.00 0.00 0.01 ± 0.032 0.00
Linolelaidic acid (C18:2 n-6 E) 0.01 ± 0.047 0.00 0.00 0.03 ± 0.072
Linoleic acid (C18:2 n-6 Z (LA)) 12.32 ± 2.643 16.10 ± 5.325 15.38 ± 5.754 15.31 ± 2.667
γ-linolenic acid (C18:3 n-6 (GLA)) 0.00 a,b 0.04 e ± 0.064 0.07 f ± 0.087 0.00
α-linolenic acid (C18:3 n-3 (ALA)) 0.33 d ± 0.103 0.48 e ± 0.149 0.45 f ± 0.121 1.64 ± 0.247
Cis 11,14-eicosadienoic acid (C20:2) 0.98 a,b,d ± 0.282 0.64 e ± 0.332 0.40 f ± 0.084 0.00
Dihono-γ-linolenic acid (C20:3 n-6 (DGLA)) 0.74 a,b,d ± 0.274 0.49 e ± 0.139 0.34 f ± 0.098 0.00
Arachidonic acid (C20:4 n-6 (AA)) 0.72 a,b,d ± 0.321 0.46 ± 0.114 0.36 ± 0.073 0.31 ± 0.078
Cis 13,16-docosadienoic acid (C22:2) 0.03 ± 0.084 0.00 0.00 0.00
Cis 4,7,10,13,16,19-docosahexadienoic acid (C22:6 n-3 (DHA)) 0.47 ± 0.240 0.36 ± 0.140 0.33 ± 0.240 0.22 ± 0.099
PUFA 15.94 ± 2.504 17.80 ± 5.038 17.48 ± 5.828 17.55 ± 2.667
UFA 62.68 ± 6.83 63.07 ± 3.62 65.78 ± 5.88 60.94 ± 6.22
SFA/UFA 0.62 ± 0,20 0.59 ± 0,09 0.53 ± 0,14 0.64 ± 0.17
n-3 PUFA 0.77 d ± 0.308 0.84 e ± 0.165 0.79 f ± 0.350 1.81 ± 0.232
n-6 PUFA 14.11 a ± 2.333 16.38 ± 4.979 16.14 ± 5.907 14.83 ± 1.756
LC-PUFA (C20-C24) 3.06 a,b,d ± 0.641 1.85 c,e ± 0.381 1.43 f ± 0.260 0.54 ± 0.158
LA/ALA 38.15 d ± 17.980 32.03 e ± 10.030 31.30 f ± 15.370 9.53 ± 0.667
AA/DHA 1.74 ± 0.812 1.54 ± 0.683 1.43 ± 1.016 1.33 ± 0.361
SD: standard deviation; PUFA: polyunsaturated fatty acids; UFA: unsaturated FAs; SFA/UFA: saturated FAs /
unsaturated FAs; LC-PUFA: long-chain PUFA; LA/ALA: linoleic acid/α-linolenic acid; AA/DHA: araquidonic
acid/docoxahexaenoic acid. (a) Significant differences (p < 0.05) between colostrum and transitional milk groups, (b)
significant differences (p < 0.05) between colostrum and mature milk groups, (c) significant differences (p < 0.05)
between transitional and mature milk groups, (d) significant differences (p < 0.05) between colostrum and infant
formula groups, (e) significant differences (p < 0.05) between transitional and infant formula groups, (f) Significant
differences (p < 0.05) between mature and infant formula groups.
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Figure 2. Fatty acid profile in human milk (colostrum n = 13; transitional milk n = 13; and mature milk
n = 12) and infant formulas ( = 7). SFA: saturated fatty acids MUFA: monounsaturated fatty cids;
PUFA: polyunsaturated atty acids and LC-PUFA: long-chain polyunsaturated fatty acids. Significant
differences (** < 0.01), (*** p < 0.001) an (**** p < 0.0001).
3.2.1. Saturated Fatty Acids (SFAs)
The saturated fatty acids identified are shown in Table 3.
The major SFA was C16:0, which is seen to decrease significantly when comparing the colostrum
group to the transitional group (p < 0.05) and the mature group (p < 0.0001) within the milk samples
(23.75%, 20.76% to 18.13% respectively). Nevertheless, a significant increase was observed between the
colostrum group nd the transitional and mature milk group (p < 0.0001) for C10:0 (0.18%; 1.06%, and
1.06%, respectively) and C12:0 (1.43%; 4.65%, and 3.82%, respectively).
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Infant formulas showed significantly lower values of C18:0 than the colostrum (p < 0.0001),
transitional (p < 0.01), and mature (p < 0.01) groups. In contrast, higher values of C12: 0 were found in
infant formulas than the colostrum (p < 0.0001), transitional (p < 0.01), and mature (p < 0.001) groups.
In addition, higher levels of C10: 0 were found relative to colostrum group (p < 0.0001), and higher
C16: 0 relative to the transitional (p < 0.05) and mature (p < 0.001) groups.
Thus, infant formulas have a higher proportion of SC-SFA (0.97% for colostrum, 1.51% for
transitional milk, 1.70% for mature milk, and 2.01% for infant formulas) and MC-SFA (27.71% for
colostrum, 30.38% for transitional milk; 26.05% for mature milk and 33.76% for infant formulas) than
human milk. In contrast, they have a lower percentage of LC-SFA (6.41% for colostrum, 5.35% for
transitional milk, 5.55% for mature milk, and 4.15% for infant formulas).
The other saturated fatty acids and overall SFA did not show significant differences between the
milk groups.
3.2.2. Monounsaturated Fatty Acids (MUFAs)
The monounsaturated fatty acids identified are shown in Table 4.
The major MUFA was C18:1 n-9 Z, with similar values being found between human milk groups
and infant formulas.
There was a decreasing trend between the colostrum group to the transitional and mature milk
groups for C16:1 n-9 Z (1.52%, 1.23%, and 1.45%, respectively); C18:1 n-7 E (1.42%, 1.12%, and 1.11%,
respectively); and C20:1 n-9 (0.97%, 0.52%, and 0.38%, respectively).
In addition, significantly higher percentages were observed for these three fatty acids in human
milk samples than in infant formulas (p < 0.01) (0.37% for C16:1 n-9 Z; 0.47% for C18:1 n-7 E; and 0.36%
for C20:1 n-9).
The other monounsaturated fatty acids and the total MUFA did not show significant differences
between the milk groups and infant formulas.
3.2.3. Polyunsaturated Fatty Acids (PUFAs)
The polyunsaturated fatty acids identified are shown in Table 5.
The major PUFA was C18:2 n-6 Z, (LA), with similar values being found between human milk
groups and infant formulas. In contrast, C18:3 n-3 (ALA) showed significantly higher values in
infant formula than in the different human milk groups (p < 0.0001). Thus, the LA/ALA ratio showed
statistically significant differences between the human milk group and infant formulas (p < 0.001).
C20:2 and C20:3 n-6 showed a significant decrease between the colostrum group and the transitional
(p < 0.01) and mature (p < 0.0001) milk groups. Whilst measurements for C22:6 n-3 (DHA) did not
show statistically significant differences, instead presenting similar trends between groups.
With regards to LC-PUFA (C20–24), greater variability was seen between the human milk and
infant formula groups. Figure 3 shows the variability of the main PUFAs in human milk and infant
formulas. The latter group did not contain C20:2, GLA, and DGLA, whilst the percentages of AA and
DHA were significantly lower than that found in human milk.
The remaining polyunsaturated fatty acids and overall PUFA did not show significant differences
between the milk groups and infant formulas.
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Forty-five cases were used t odel that discriminates between the human milk
and i fant formula samples. Thirty-six predictor variables ere 6 displays the
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1 126.3990 87.58 0.9961 0.0002 210.5987 0.0000 *
2 15.9167 11.03 0.9610 0.0197 94.2629 0.0282 *
3 2.0021 1.39 0.8166 0.3331 26.3837 0.8214
* : Significant differences (p < 0.05).
In this case, our first discriminant function has a relative variance percentage close to 100%
(87.58%), while the second and third discriminant function is only able to explain 11.03% and 1.39% of
the variance of the data, respectively. The p-value of discriminant functions 1 and 2 are less than 0.05,
whereby both discriminant functions are statistically significant with a 95.0% confidence level.
In addition, the canonical correlation of the first and second functions is closer to 1. These functions
allowed 91.1% of groups to be classified (100% for infant formulas versus 83.3% of mature human milk).
Finally, Wilk’s Lambda is also closer to 0 in the first two discriminant functions.
Taken together, results indicate that our first two discriminant functions are capable of separating
the data much better than the third function.
A graphical representation of the two dimensions is shown in Figure 4, according to the first and
second discriminating functions.
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4. Discussion
The results of the present study show that the average characteristics relating to the fatty acid
composition of human milk can be summarized as follows. Palmitic acid (≈20%), oleic acid (≈44%),
and linoleic acid (≈15%) were the predominant fatty acids in the colostrum, transitional, and mature
milk groups, and in t e infant formulas. These represented between 76.67% and 81.94% of the total
fatty acids. This trend is similar to that found by Yang et al., hich was between 77.98% and 78.57% [22].
Next, we consider the results relating to yristic cid (≈4%) and stearic acid (≈6%).
All f these values were very similar to those describ y oth r authors. Yang et al. [23] found
similar values in palmitic acid (21.77%), myristic acid (3.91%), and stearic acid (5.14%); but found lower
values in oleic a id (33.32%) and higher values in linolei acid (22.54%). However, Zou et al. [24] reported
more similar values with resp ct to pal itic acid (20.3%), linoleic acid (17.1%), myristic acid (4.9%), and
stearic acid (6.0%). On the other hand, they also identified lower percentages of oleic acid (34.9%).
4.1. Saturated Fatty Acids (SFAs)
Total saturated fatty acid (SFA) content remained stable across all of the milk groups [24]. Human milk
typically contains approximately 34% to 47% saturated fatty acids, mainly palmitic acid (17–25%) [7,22].
Similar values were found in other studies [10,13,25]. The colostrum and infant formula groups presented
similar percentages of this SFA (23.75% and 23.09%, respectively). However, in human milk, palmitic
acid is esterified with triglycerides in positio 2 (position β), whereas unmodified il fat of infant
formulas is esterified in p sitio 1 and 3. The specific distribution of fatty acids in the triglyceride pl ys
a key role in the digestion and absorption of lipids. It appears that this modification f fat decreases the
stability and q antity of calcareous soa s in feces, thus decreasing its consistency [24–26].
Oth fatty acids, such as C10:0 and C12:0 increas from one la tation stage to the next. This trend
was v ry similar to that found in another Spanish study [10] (0.66%, 1.66%, and 1.63%) for C10:0 and
(3.49%, 6.97%, and 6.28%) for C12:0 in colostrum, transitional, and ma ure milk, respectively.
Therefor , infant formulas have a higher proportion of SC-SFA MC-SFA than human milk,
possibly due to the addition of vegetable oils [26]. MC-SFA are commonly supplemented and incorporated
into these infan formula because they can be directly ab orbed by th por l vein and rapidly generate
en rgy for infants [27]. However, this has bee related to an increase in the level of total and low-density
lipoprotein (LDL) cholesterol concentration in plasma leading o a high risk of c rdiovascular disease.
On the other hand, LC-SFA is reported to be neutral concerning its effects on lipoprotein cholesterol
levels [28].
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Despite this, overall lauric and myristic acid content is recommended to not exceed 20% of total
fat in infant formulas, with content being 10.88% in the present case [29].
4.2. Monounsaturated Fatty Acids (MUFAs)
Total monounsaturated fatty acid (MUFA) remained stable in all milk samples (45.99% for
colostrum, 43.34% for transitional, and 46.99% for mature milk group). This trend has also been
described by other authors [30]. Barreito et al. reported a percentage of 44.1%.
Oleic acid (C18:1 n-9) constitutes more than 90% of the total MUFAs, finding similar values in
human milk groups and infant formulas. This is fundamentally linked to the consumption of olive oil,
representing levels greater than 40% [6,15].
These values are higher than those found in other studies, both Spanish and European studies,
possibly because southern Spain shows higher levels of adherence to the Mediterranean diet [31].
This may be due to the potentially high adherence to the Mediterranean diet of our participants
which is composed of foods rich in oleic acid, especially for the high consumption of extra virgin oil.
According to the data offered by ministry of agriculture, food and environment (MAGRAMA) in 2018,
Andalusía purchases and consumes more extra virgin olive oil than any other autonomous community,
accounting for 25.99% of the volume distributed across Spain (L) [32].
C16:1 n-9, C18:1 n-7, and C20:1 n-9 were the three most abundant MUFAs in human milk after oleic
acid, with a percentage of around 3–4%, whilst the percentage present in infant formulas was 1.2%.
The results of a previous study indicate that the majority of commercially available IF do not contain
scientifically recommended amounts of vaccenic acid, and that their fatty acid composition is deficient
in comparison with human milk [33]. Vaccenic acid is the major trans-fatty acid in ruminant milk fat.
It is unique in that it may provide cis-9, trans-11-octodecadienoic (cis 9, trans 11-C18:2; also known as
rumenic acid) to the consumer through endogenous desaturation by the ∆-9 desaturase enzyme [34].
Rumenic acid is the most common conjugated linoleic acid (CLA) isomer and it has been shown
to promote various beneficial health-related effects, including anti-carcinogenic, anti-atherosgenic,
anti-diabetic, and immune-modulating effects, in addition to effects on body composition and fat
metabolism [35–37].
4.3. Polyunsaturated Fatty Acids (PUFAs)
Concentrations of PUFA in human milk are relatively stable during the first year of life. AA typically
constitutes 1% (0.72%) in colostrum and 0.5% in mature milk (0.36%); DHA is approximately equivalent to
0.5% in colostrum (0.47%) and 0.25% in mature milk (0.33%) [16]. Also, it typically contains approximately
12% to 26% n-6 PUFA and 0.8% to 3.6% n-3 PUFA [7].
Moreover, essential fatty acid (EFA) content varies depending on the stage of lactation, particularly
LA levels (12.32% for colostrum; 16.10% for transitional; and 15.38% for mature milk). Zou et al. showed
this trend in the results of their study (21.01%, 21.05%, and 25.58% for colostrum, transitional, and mature
milk, respectively) [23], although the values of our study were lower. Values, however, were similar to
those reported by Ribeiro et al. [38] (15.46% for samples 7 days postpartum and 16.20% for samples at
4 weeks postpartum).
DHA, AA, and DGLA content also showed a decrease according to the stage of lactation [38,39],
finding higher values in colostrum than in transitional and mature milk groups [23]. Only a slight
increase in GLA was observed, correlated with a reduction in inflammation after childbirth. GLA is
the substrate for DGLA synthesis, another anti-inflammatory fatty acid [36,37,40] Fu et al. evaluated
the DHA and arachidonic acid (AA) levels in human milk according to country and region, reporting
similar values (0.42% for DHA and 0.71% for AA) for Spain to those found in the present study [41].
However, higher levels of ALA were observed in mature milk compared to the colostrum and
transitional groups, as has also been described by other authors [15].
In infant formulas, LA percentage (15.31%) was similar to that found in human milk (14.6%).
However, the content of AA (0.31%) and DHA (0.22%) was lower than in human milk (0.51% and 0.39%,
Nutrients 2019, 11, 3055 13 of 16
respectively), especially when considering the colostrum stage. Conversely, ALA values were also much
higher in infant formulas than in human milk (1.64% and 0.42%, respectively). DHA experiences a longer
and more complicated synthesis which limits the conversion rate of ALA/DHA [42]. This trend is shown
in Figure 2.
For this reason, infant formulas present a significantly higher percentage of n-3 PUFA than that
seen in the different groups of human milk. This is due to their high amount of α-linolenic acid.
Codex Alimentarius stipulate that the AA and DHA content of infant formulas should, at least,
have the same concentration [43]. The content of these fatty acids in our infant formulas was 0.31% and
0.22%, respectively. These values being similar to those described by Chen et al. [27], which reported
values of 0.41% for AA and 0.23% for DHA.
These values are below estimated averages for AA and DHA in human milk samples studied by
Brenna et al. [42]. These authors included 84 studies and reported that the worldwide mean concentration
in human milk was 0.47% ± 0.13% for AA and 0.32% ± 0.22% for DHA. These values are very similar to
those uncovered in the present sample (0.51% for AA and 0.39% for DHA).
The AA/DHA ratio did not vary with increasing milk maturation, however the LA/ALA ratio was
significantly higher in the colostrum, transitional, and mature milk groups than in infant formulas
(38.15%, 32.03%, 31.30%, and 9.53%, respectively). It is important to note that this ratio is within the
guideline range of 5:1 and 15:1 suggested by the ESPHGAN Committee on Nutrition (European Society
for Pediatric Gastroenterology Hepatology and Nutrition) [29].
4.4. Discriminant Analysis
An eigenvalue in discriminant analysis is the characteristic root of each function, that is, it is
an indication of how well that function differentiates the groups, and the larger the eigenvalue is,
the better the function differentiates the groups [44].
In the present study, the infant formula group shows left-handside displacement on the graph,
while the human milk groups are found to the right of the graph. Differences between the colostrum,
transitional, and mature human milk groups can be established.
This indicates that all of the present samples can be grouped and differentiated from each other
according to their fatty acid profile. Infant formulas are distinct from the human milk groups, largely
due to the differences described in their LC-PUFAs. In addition, it is interesting to observe that the
different human milk samples can be assigned to independent groups, following the observation
that samples belonging to the colostrum group have a different composition than the other samples
(transitional and mature groups).
In conclusion, this method was proven to be a useful tool for studying the relationships between
oils according to their fat composition [44].
4.5. Limitations and Strenghts
Some limitations should be acknowledged. The small sample size used in the present study is
a limitation, although we did not observe significant differences in the fatty acid profile of lactating
women according to the anthropometric variables studied, such as weight, height, or BMI (normal
BMI and those with a BMI above 25 kg/m2); this also being the case for the other variables described.
On the other hand, data on human milk has been previously reported for many European countries
and cultures but no recent data about milk from lactating women relates to southern Spain [10,22].
This means there is an interest in carrying out this study with lactating women in Granada. It also
constitutes a strength of the present study that it provides new fatty acid data in human milk,
as well as infant formulas that are currently commercial, through the use of novel analytical techniques
(GC-MS/MS).
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5. Conclusions
The outcome of the present study showed that the fatty acid profile of human milk samples varies
throughout lactation. This variability in the profile of fatty acids between the different samples of
human milk justifies that is not a static fluid and changes over time, adapting to the nutritional needs
of the infant. However, infant formulas are rather uniform with respect to their composition.
According to the results, despite the fatty acid profile being similar in infant formulas and in
human milk in terms of total SFA, MUFA, and PUFA; significant differences were found in some
important fatty acids (such as ALA, GLA, DHA, or AA) between different human milk groups and
infant formulas. Further, more evident statistically significant differences were observed between the
colostrum group and the other samples.
Nevertheless, although infant formulas are enriched with the main LC-PUFAs, typically rich in
LA, and in some cases with sufficient contributions of ALA, they tend to have low DHA, AA, and GLA
content with respect to human milk. These fatty acids are important for fetal growth, and brain and
retina development during pregnancy and the early years of life. Scientific evidence has shown that
non-breastfed children suffer from a greater prevalence, severity, and longevity of diseases, not only
during the time of breastfeeding but many years later.
Furthermore, the distribution of palmitic acid in infant formulas should resemble that of human
milk as the specific distribution of fatty acids in triglyceride plays a key role in the digestion and
absorption of lipids.
In conclusion, this experimental work can be used to ensure that infant formulas are as similar as
possible to human milk and reproduces as close as possible the complexity of human milk composition.
This is important in circumstances where breastfeeding is impossible, insufficient, or undesired.
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